$JAZZ Headlines A stock that protects your ident
Post# of 144491
Posted On: 02/25/2014 10:08:05 AM
$JAZZ Headlines
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 11:15 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 1:56 a.m. Sept. 6, 2012 - MarketWatch.com
The bull market is starting to stray 12:02 a.m. Feb. 16, 2012 - The Trading Deck
Nasdaq sustains break to 11-year highs 11:31 a.m. Feb. 7, 2012 - Michael Ashbaugh
Nasdaq sustains break to 11-year highs 11:00 a.m. Feb. 7, 2012 - Michael Ashbaugh
January uptrend meets major resistance 11:15 a.m. Jan. 24, 2012 - Michael Ashbaugh
U.S. benchmarks hesitate at major resistance 10:49 a.m. Jan. 24, 2012 - Michael Ashbaugh
Mr. Market Loves Jazz Pharmaceuticals, Time To Sell 3:47 a.m. Today - Seeking Alpha
Jazz Pharma To Guide 2014 With New Drugs On Board 11:48 a.m. Feb. 24, 2014 - Investors Business Daily
Jazz Pharmaceuticals Moves Up In Market Cap Rank, Passing Waters 4:40 p.m. Feb. 20, 2014 - TheStreet.com
Insider Trading Alert - MJN, JAZZ And CLB Traded By Insiders 11:30 a.m. Feb. 18, 2014 - TheStreet.com
Biotech Remains on Fast Track 11:00 a.m. Feb. 18, 2014 - RealMoney.com
A Lean, Wary Post-Bailout Ireland Begets Rising Stocks 4:17 p.m. Feb. 14, 2014 - Investors Business Daily
IPO Preview: Concert Pharmaceuticals 1:00 a.m. Feb. 13, 2014 - Seeking Alpha
Top Ranked Healthcare ETF in Focus: XPH - ETF News And Commentary 8:01 a.m. Feb. 12, 2014 - Zacks.com
Bull of the Day: Endocyte (ECYT) - Bull of the Day 5:03 a.m. Feb. 12, 2014 - Zacks.com
Jazz Pharma Still Making Investors Sing 11:29 a.m. Feb. 11, 2014 - TheStreet.com
Actavis, Valeant, Jazz: New Roles For Specialty Pharma 1:12 p.m. Feb. 7, 2014 - Investors Business Daily
Jazz, Valeant Pace Highly Rated Ethical Drugs Group 4:21 p.m. Feb. 6, 2014 - Investors Business Daily
3 Health Care Stocks Dragging The Sector Down 12:03 p.m. Feb. 6, 2014 - TheStreet.com
IBD's Price, Volume Bars In Color Help Identify Bases 4:33 p.m. Feb. 3, 2014 - Investors Business Daily
Questcor Defies Market Turmoil, Works On New Base 4:49 p.m. Jan. 31, 2014 - Investors Business Daily
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
How To Find, Buy Leading Stocks, Not Laggards 4:02 p.m. Jan. 27, 2014 - Investors Business Daily
Analyst Team Sees Strong Biotech Buyout Market in 2014 10:35 a.m. Jan. 27, 2014 - 247WallSt.com
Jazz Pharmaceuticals plc Completes Tender Offer For Gentium S.p.A. Shares 8:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2013 Fourth Quarter and Full Year Financial Results on February 25, 2014 4:07 p.m. Feb. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 4:05 p.m. Feb. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland 8:05 a.m. Feb. 10, 2014 - PR Newswire - PRF
CHD Bioscience Appoints Dr. Catherine Angell Sohn to its Board of Directors 9:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 2:24 a.m. Jan. 23, 2014 - PR Newswire - PRF
Critical Alerts For Vodafone, PetSmart, Gamestop, Constellation brands, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Jan. 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness 8:05 a.m. Jan. 13, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 8:00 a.m. Jan. 9, 2014 - PR Newswire
Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13 4:15 p.m. Jan. 6, 2014 - PR Newswire
Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
InVivo Names Mark Perrin as Its New Chief Executive Officer 4:30 p.m. Dec. 23, 2013 - BusinessWire
Gentium S.p.A. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Jazz Pharmaceuticals 11:12 a.m. Dec. 20, 2013 - BusinessWire
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share 4:48 p.m. Dec. 19, 2013 - GlobeNewswire
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share 4:43 p.m. Dec. 19, 2013 - PR Newswire
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals 8:00 a.m. Dec. 19, 2013 - PR Newswire
Quarterly Changes to the NASDAQ OMX Q-50 Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Corporate Directors From ON Semiconductor, Carpenter Technology and AARP Become NACD Fellows 9:01 a.m. Dec. 3, 2013 - GlobeNewswire
Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics 8:00 a.m. Nov. 28, 2013 - PR Newswire
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 11:15 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 1:56 a.m. Sept. 6, 2012 - MarketWatch.com
The bull market is starting to stray 12:02 a.m. Feb. 16, 2012 - The Trading Deck
Nasdaq sustains break to 11-year highs 11:31 a.m. Feb. 7, 2012 - Michael Ashbaugh
Nasdaq sustains break to 11-year highs 11:00 a.m. Feb. 7, 2012 - Michael Ashbaugh
January uptrend meets major resistance 11:15 a.m. Jan. 24, 2012 - Michael Ashbaugh
U.S. benchmarks hesitate at major resistance 10:49 a.m. Jan. 24, 2012 - Michael Ashbaugh
Mr. Market Loves Jazz Pharmaceuticals, Time To Sell 3:47 a.m. Today - Seeking Alpha
Jazz Pharma To Guide 2014 With New Drugs On Board 11:48 a.m. Feb. 24, 2014 - Investors Business Daily
Jazz Pharmaceuticals Moves Up In Market Cap Rank, Passing Waters 4:40 p.m. Feb. 20, 2014 - TheStreet.com
Insider Trading Alert - MJN, JAZZ And CLB Traded By Insiders 11:30 a.m. Feb. 18, 2014 - TheStreet.com
Biotech Remains on Fast Track 11:00 a.m. Feb. 18, 2014 - RealMoney.com
A Lean, Wary Post-Bailout Ireland Begets Rising Stocks 4:17 p.m. Feb. 14, 2014 - Investors Business Daily
IPO Preview: Concert Pharmaceuticals 1:00 a.m. Feb. 13, 2014 - Seeking Alpha
Top Ranked Healthcare ETF in Focus: XPH - ETF News And Commentary 8:01 a.m. Feb. 12, 2014 - Zacks.com
Bull of the Day: Endocyte (ECYT) - Bull of the Day 5:03 a.m. Feb. 12, 2014 - Zacks.com
Jazz Pharma Still Making Investors Sing 11:29 a.m. Feb. 11, 2014 - TheStreet.com
Actavis, Valeant, Jazz: New Roles For Specialty Pharma 1:12 p.m. Feb. 7, 2014 - Investors Business Daily
Jazz, Valeant Pace Highly Rated Ethical Drugs Group 4:21 p.m. Feb. 6, 2014 - Investors Business Daily
3 Health Care Stocks Dragging The Sector Down 12:03 p.m. Feb. 6, 2014 - TheStreet.com
IBD's Price, Volume Bars In Color Help Identify Bases 4:33 p.m. Feb. 3, 2014 - Investors Business Daily
Questcor Defies Market Turmoil, Works On New Base 4:49 p.m. Jan. 31, 2014 - Investors Business Daily
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
How To Find, Buy Leading Stocks, Not Laggards 4:02 p.m. Jan. 27, 2014 - Investors Business Daily
Analyst Team Sees Strong Biotech Buyout Market in 2014 10:35 a.m. Jan. 27, 2014 - 247WallSt.com
Jazz Pharmaceuticals plc Completes Tender Offer For Gentium S.p.A. Shares 8:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2013 Fourth Quarter and Full Year Financial Results on February 25, 2014 4:07 p.m. Feb. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 4:05 p.m. Feb. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland 8:05 a.m. Feb. 10, 2014 - PR Newswire - PRF
CHD Bioscience Appoints Dr. Catherine Angell Sohn to its Board of Directors 9:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 2:24 a.m. Jan. 23, 2014 - PR Newswire - PRF
Critical Alerts For Vodafone, PetSmart, Gamestop, Constellation brands, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Jan. 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness 8:05 a.m. Jan. 13, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 8:00 a.m. Jan. 9, 2014 - PR Newswire
Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13 4:15 p.m. Jan. 6, 2014 - PR Newswire
Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
InVivo Names Mark Perrin as Its New Chief Executive Officer 4:30 p.m. Dec. 23, 2013 - BusinessWire
Gentium S.p.A. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Jazz Pharmaceuticals 11:12 a.m. Dec. 20, 2013 - BusinessWire
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share 4:48 p.m. Dec. 19, 2013 - GlobeNewswire
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share 4:43 p.m. Dec. 19, 2013 - PR Newswire
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals 8:00 a.m. Dec. 19, 2013 - PR Newswire
Quarterly Changes to the NASDAQ OMX Q-50 Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Corporate Directors From ON Semiconductor, Carpenter Technology and AARP Become NACD Fellows 9:01 a.m. Dec. 3, 2013 - GlobeNewswire
Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics 8:00 a.m. Nov. 28, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼